Picture of Essex Bio-Technology logo

1061 — Essex Bio-Technology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareAdventurousSmall CapContrarian

Brief: Essex Bio-Technology Says Got Approval To Commercialise Diquafosol Sodium Eye Drops In PRC

Aug 14 (Reuters) - Essex Bio-Technology Ltd  1061.HK :
    * APPROVAL TO COMMERCIALISE PRESERVATIVE-FREE UNIT-DOSE
DIQUAFOSOL
SODIUM EYE DROPS IN PRC

Further company coverage:  1061.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Essex Bio-Technology

See all news